|
[1] Schumacher M, Kelkel M, Dicato M, et al. Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer. Biotechnology Advances, 2011, 29(5): 531-547.
[2] Dharmaraj S. Marine streptomyces as a novel source of bioactive substances. World Journal of Microbiology and Biotechnology, 2010, 26(12): 2123-2139.
[3] 管华诗, 王曙光. 中华海洋本草. 2009, 232-259. Guan S H, Wang S G. China marine materia medica.2009, 232-259.
[4] 邢桂兰, 田树红, 符健. 海洋细菌SSQ500的鉴定及其发酵产物抗肿瘤作用机制研究. 微生物学通报, 2013, 40(6): 1068-1073. Xing G L, Tian S H, Fu J. Identification of marine bacteria SSQ500 and the antitumor mechanism of fermentation products. Microbiology China,2013, 40(6): 1068-1073.
[5] Newman D J, Cragg G M. Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Marine Drugs, 2014, 12(1): 255-278.
[6] Huyck T K, Gradishar W, Manuguid F, et al. Eribulin mesylate. Nature Reviews Drug Discovery, 2011, 10(3): 173-174.
[7] Sarfaraj H M, Sheeba F, Saba A, et al. Marine natural products: a lead for anti-cancer. Indian Journal of Marine Sciences, 2012, 41: 27-39.
[8] Jiang C S, Muller W E G, Schroder H C, et al. Disulfide and multisulfide-containing metabolites from marine organisms. Chemical Reviews, 2011, 112(4): 2179-2207.
[9] Kawagishi F, Toma T, Inui T, et al. Total synthesis of ecteinascidin 743. Journal of the American Chemical Society, 2013, 135(37): 13684-13687.
[10] Pettit G R, Kamano Y, Herald C L, et al. Structure of bryostatin 4. An important antineoplastic constituent of geographically diverse Bugula neritina (Bryozoa). Journal of the American Chemical Society, 1984, 106(22): 6768-6771.
[11] Liu Y, Morgan J B, Coothankandaswamy V, et al. The Caulerpapigment caulerpin inhibits HIF-1 activation and mitochondrial respiration. Journal of Natural Products, 2009, 72(12): 2104-2109.
[12] Fuller R W, Cardellina J H, Kato Y, et al. A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines. Journal of medicinal chemistry, 1992, 35: 3007-3011.
[13] Lin A S, Engel S, Smith B A, et al. Structure and biological evaluation of novel cytotoxic sterol glycosides from the marine red alga Peyssonnelia sp.. Bioorganic & Medicinal Chemistry, 2010, 18(23): 8264-8269.
[14] Colas S, Mahéo K, Denis F, et al. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clinical Cancer Research, 2010, 12(19): 5879-5886.
[15] Cheng R B, Lin X Z, Wang Z K, et al. Establishment of a transgene expression system for the marine microalga Schizochytrium by 18S rDNA-targeted homologous recombination. World Journal of Microbiology and Biotechnology, 2011, 27(3): 737-741.
[16] Wyche T P, Hou Y, Braun D, et al. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp.. The Journal of Organic Chemistry, 2011, 76(16): 6542-6547.
[17] Lam K S, Lloyd G K, Neuteboom S T C, et al. From natural product to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent. Natural Products Chemistry for Drug Discovery, 2010, 355-373.
[18] Zheng L H, Wang Y J, Sheng J, et al. Antitumor peptides from marine organisms. Marine Drugs, 2011, 9(10): 1840-1859.
[19] Gerwick W H, Hamel E, White J D, et al. Integrating disciplines in the natural products sciences: the story of Curacin A. Planta Medica, 2012, 78(11):1-19.
[20] Lee J, Currano J N, Carroll P J, et al. Didemnins, tamandarins and related natural products. Natural Product Reports, 2012, 29(3): 404-424.
[21] Sivapathasekaran C, Das P, Mukherjee S, et al. Marine bacterium derived lipopeptides: characterization and cytotoxic activity against cancer cell lines. International Journal of Peptide Research and Therapeutics, 2010, 16(4): 215-222.
[22] Moushumi P A, Jayachandran S. Induction of apoptosis and cell cycle arrest by bis(2-ethylhexyl) phthalate produced by marine Bacillus pumilus MB 40. Chemico-biological Interactions, 2012, 195(2): 133-143.
[23] Maloney K N, Macmillan J B, Kauffman C A, et al. Lodopyridone, a structurally unprecedented alkaloid from a marine actinomycete. Organic Letters, 2009, 11(23): 5422-5424.
[24] 陈劲平, 林逸君, 敬科举, 等. 不同流加策略对内生真菌拟茎点霉生产去乙酰真菌环氧乙酯的影响. 厦门大学学报(自然科学版), 2010, 49(5): 676-681. Chen J P, Lin Y J, Jing K J, et al. Effect of different feeding modes on deacetylmycoepoxydiene production by an endophytic fungi Phomopsis sp. Journal of Xiamen University (Natural Science), 2010, 49(5):676681.
[25] 管华诗. 把握海洋药物研发的历史机遇. 中国海洋药物, 2013, 1: 14-15. Guan H S. Grasp the historical opportunity of marine drug. Chinese Journal of Marine Drugs, 2013, 1: 14-15.
[26] 张书军, 焦炳华. 世界海洋药物现状与发展趋势. 中国海洋药物, 2012, 2: 012. Zhang S J, Jiao B H. Current situation and development trend of marine drugs. Chinese Journal of Marine Drugs, 2012, 2: 012.
[27] 闫娟娟. 我国创新药物实现产业化的策略探讨. 中国医药管理杂志, 2011, 19(5): 397-399. Yan J J. Discussion on the strategy for industrialization of innovative medicine in our country. Journal of Traditional Chinese Medicine Management, 2011, 19(5): 397-399.
[28] Montaser R, Luesch H. Marine natural products: a new wave of drugs?. Future Medicinal Chemistry, 2011, 3(12): 1475-1489.
[29] 孙继鹏, 易瑞灶, 吴皓, 等. 海洋药物的研发现状及发展思路. 海洋开发与管理, 2013,3:7-13. Sun J P, Yi R Z, Wu H, et al. Research status and development ideas of marine drugs. Ocean Development and Management, 2013,3:7-13.
|
